Penciclovir cream is indicated for the treatment of recurrent cold sores (herpes labialis) on the lips and face of adults and children aged 12 years old and older.
The district court determined that the patent is invalid on two separate grounds – lack of written description and lack of enablement, the company said.
Lannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH.
